Journal Article
|ResearchTreatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, Menzies D, Turkova A, Achar J, Amanullah F, Barry PM, Becerra M, Chan ED, Chan PL, Ioana Chiotan D, Crossa A, Drobac PC, Fairlie L, Falzon D, Flood J, Gegia M, Hicks RM, Isaakidis P, Kadri S, Kampmann B, Madhi SA, Marais E, Mariandyshev A, Méndez-Echevarría A, Moore BR, Nargiza P, Ozere I, Padayatchi N, ur-Rehman S, Rybak N, Santiago-Garcia B, Shah NS, Sharma SK, Shim TS, Skrahina A, Soriano-Arandes A, van den Boom M, van der Werf MJ, van der Werf TS, Williams BG, Yablokova E, Yim JJ, Furin J, Hesseling AC
Abstract
An estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacterium tuberculosis resistant to isoniazid and rifampin) each year. Little is known about the optimal treatment for these children.
Subject Area
Languages
English
